BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan AQ, Rashid K, Alamodi AA, Raza SS, Uddin S. Recent developments in unraveling signaling mechanisms underlying drug resistance due to cancer stem-like cells. Current Opinion in Pharmacology 2020;54:130-41. [DOI: 10.1016/j.coph.2020.09.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wong VKW. Editorial overview: New technologies in 2020: Drug resistance. Curr Opin Pharmacol 2020;54:iii-vi. [PMID: 33357714 DOI: 10.1016/j.coph.2020.12.002] [Reference Citation Analysis]
2 Khan AQ, Al-Tamimi M, Uddin S, Steinhoff M. F-box proteins in cancer stemness: An emerging prognostic and therapeutic target. Drug Discov Today 2021:S1359-6446(21)00314-7. [PMID: 34265459 DOI: 10.1016/j.drudis.2021.07.006] [Reference Citation Analysis]
3 Kazi JU. Mechanisms of Anticancer Therapy Resistance: The Role of Cancer Stem Cells. Int J Mol Sci 2020;21:E9006. [PMID: 33260802 DOI: 10.3390/ijms21239006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang X, Du ZW, Xu TM, Wang XJ, Li W, Gao JL, Li J, Zhu H. HIF-1α Is a Rational Target for Future Ovarian Cancer Therapies. Front Oncol 2021;11:785111. [PMID: 35004308 DOI: 10.3389/fonc.2021.785111] [Reference Citation Analysis]